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ABSTRACT Red blood cell 2,3 diphosphoglycerate (2,3-DPG) levels increase 
after ascent to high altitude. Studies were undertaken to identify the biochemical 
mechanisms responsible for eliciting the 2,3-DPG response in several types of 
subjects. These included (1) short-term exposure to 3400 m in ten subjects; (2) ex- 
posure to  4300 m in an additional ten subjects; (3) studies in 28 high-altitude 
normal residents of 3100 m; and (4) studies in 28 high-altitude residents with 
chronic mountain polycythemia. Controls were 41 residents of 240 m. Regression 
analysis identified the glycolytic variables, termed “key variables,” on which 
variation in 2,3-DPG levels was dependent (P < .05). Key variables common to the 
short-term studies were glucose-6-phosphate, phosphoenolpyruvate, and the ratio 
of the levels of adenosine diphosphate to  adenosine triphosphate. The positions of 
these key variables in the glycolytic pathway and their mean levels suggest 
erythrocyte hexokinase and pyruvate kinase activation as possible enzymatic 
mechanisms. Key variables unique to the 3400 m study suggested phosphofructo- 
kinase activation also acted to increase 2,3-DPG levels. 2,3-DPG levels in the 
normal 3100 m residents were not different from low-altitude values, and 2,3-DPG 
levels in these samples did not appear to be dependent on any of the glycolytic 
variables examined. Among the high-altitude residents with polycythemia, higher 
2,3-DPG levels were dependent on glucose-6-phosphate, fructose diphosphate, di- 
hydroxyacetone phosphate, and the ratio of adenosine diphosphate to adenosine 
triphosphate levels. The positions of these variables in the glycolytic pathway and 
their mean levels suggested activation of the hexokinase and phosphofructokinase 
enzymes. 
Components of the oxygen transport system 
respond to high altitude in ways which help 
compensate for the reduced partial pressure of 
oxygen. The red blood cell responds metaboli- 
cally with a build-up of 2,3-diphosphoglycerate 
(2,3-DPG) levels (Lenfant et al., ’68; Eaton et 
al., ’69). Increased 2,3-DPG levels decrease 
hemoglobin-oxygen affinity, or shift the oxy- 
gen dissociation curve rightward, which can be 
expected to augment tissue oxygen delivery if 
arterial oxygen saturation remains high. 
Our purpose was to  identify the biochemical 
mechanisms that were most likely responsible 
for the previously reported increase in 2,3-DPG 
levels. Studies were conducted (1) under base- 
line conditions and during short-term (8-10 
days) high-altitude exposure to 3400 m a t  
Climax, Colorado, and to 4300m on Pike’s 
Peak, Colorado; (2) among normal residents of 
Leadville, Colorado (3100 m); (3) among resi- 
dents of Leadville with chronic mountain poly- 
cythemia; and (4) for comparative purposes, 
among residents of Ann Arbor, Michigan 
(240 m). Possible biochemical mechanisms 
were defined by first identifying the glycolytic 
intermediates on which the variation in 2,3- 
DPG levels was statistically dependent. The 
positions of these intermediates in the glyco- 
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lytic pathway and the changes in their mean 
levels after high-altitude exposure were in- 
spected. Inferences were then drawn concern- 
ing the enzymatic mechanisms most likely re- 
sponsible for elevating 2,3-DPG levels. These 
inferences are based both upon the data of this 
paper and the prior knowledge of the rate-limit- 
ing enzymes in human red cell glycolysis. 
An understanding of the mechanisms re- 
sponsible for 2,3-DPG control is critical for un- 
derstanding the red blood cell metabolic re- 
sponse to high altitude and for the ultimate 
goal of understanding genetic adaptation of the 
red blood cell to  high altitude. The present 
studies advance this goal insofar as the exami- 
nation of the red blood cell metabolic response 
permits the analysis of the effects of high al- 
titude to move closer to the level of gene action. 
Knowledge about 2,3-DPG control is also im- 
portant for understanding red blood cell re- 
sponse to the hypoxic stresses of cardiovascu- 
lar, pulmonary and hematological disorders. 
Study groups 
Short-term studies (Climax and Pike’s Peak) 
Five male and five female adult Caucasian 
laboratory personnel from Ann Arbor, Michi- 
gan (240 m), were brought to the 3400 m eleva- 
tion of Climax, Colorado, and remained there 
for eight days. Male-female mean sex differ- 
ences in this sample (and the Pike’s Peak study) 
were removed by simple linear regression. 
Blood samples were drawn before ascent in Ann 
Arbor and after six hours, two days, four days, 
six days, and eight days in Climax. Informed 
consent was obtained from these and the other 
subjects in the short- and long-term studies. 
Seven US. Army enlisted men and three 
female laboratory personnel were housed on 
top of Pike’s Peak, elevation 4300 m, for ten 
days. All subjects were Caucasian residents of 
Denver, Colorado (1600 m) except one who had 
come from a lower altitude (240 m). Blood sam- 
ples were drawn before ascent in Denver and 
then after six hours, two days, four days, seven 
days, and ten days on Pike’s Peak. 
Long-term studies (Leadville and Ann Arbor) 
Normal high-altitude residents consisted of 
28 Caucasian males who had lived in Leadville, 
Colorado (3100m), for more than one year. 
None reported having any difficulty in adjust- 
ing to  Leadville’s altitude, and all had hemato- 
crits of less than 55 volumes percent. 
Twenty-eight males, also Caucasian resi- 
dents of Leadville, Colorado (3100m), for at 
least one year, with chronic mountain polycy- 
MATERIALS AND METHODS 
themia were chosen from the records of the St. 
Vincent’s Hospital in Leadville. These subjects 
were identified on the basis of having hemato- 
wits consistently above 55 volumes percent in 
the absence of phlebotomy. 
Forty-one healthy male Caucasian residents 
of Ann Arbor, Michigan (240 m), made up the 
low-altitude sample. All had lived in Ann 
Arbor for at least one year. 
Study uariables. Blood (20 ml) from the ante- 
cubital vein was drawn to measure hematocrit 
using the capillary tube method. Well-mixed 
samples (0.5 ml) were immediately precipi- 
tated in trichloroacetic acid, frozen in dry ice 
and transported to Ann Arbor for determina- 
tion of 2,3-diphosphoglycerate and adenosine 
triphosphate levels enzymatically (Kornberg, 
’50; Brewer and Powell, ’66; Keitt, ’71). Ad- 
ditional well-mixed samples (10 ml) were 
precipitated immediately in perchloric acid, 
frozen in dry ice and transported to Ann Arbor 
for measuring glucose-6-phosphate, fructose- 
6-phosphate, fructose diphosphate, dihydroxy- 
acetone phosphate, 3-phosphoglycerate, 2- 
phosphoglycerate, phosphoenolpyruvate, 
pyruvate, lactate, and adenosine diphosphate 
using enzymatic methods of Minakami et al. 
(’65) as modified by Oelshlegel et al. (‘72). He- 
moglobin was read colorimetrically from 
well-mixed hemolysates that had been frozen 
and transported to Ann Arbor. 
Statistics. Regression analysis was used to 
assess the relationship between variation in 
2,3-DPG levels and the variation in each of the 
other glycolytic intermediates or cofactors. The 
coefficient of determination (9) was computed 
for each variable in each study group and, in 
the short-term studies, at each measurement 
time. Computations were performed for the 
glycolytic variables when expressed both in 
pmoles/gm Hb and in pmoles/liter red blood 
cell water. Variables whose r2 values were sig- 
nificant (P < .05) for both units of measure- 
ment were termed “key variables” insofar as it 
is variation in these variables that is most 
closely linked (statistically) to variation in 
2,3-DPG levels. 
In the short-term studies, change in the 
mean levels of the variables over all the meas- 
urement times was determined with the Hotel- 
ling TZ test. Comparison of variable means in 
the Ann Arbor normal with the Leadville nor- 
mal and Leadville polycythemic samples was 
made using the two-sample (Student’s) t-test. 
The Scheffe correction for multiple compari- 
sons was used to avoid the inflation of type I 
errors incurred by multiple use of the t-test. 
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Mean differences are reported as significant 
when P < .05. Values are reported as mean 
? SEM. 
RESULTS 
Short-term studies (Climax and Pike’s Peak) 
2,3-DPG levels increased during short-term 
exposure at Climax (3400 m) and Pike’s Peak 
(4300 m) (Fig. 1, Tables 1 and 2). Maximal in- 
creases of 1520% above baseline values occur- 
red at both altitudes. The rise in 2,3-DPG levels 
a t  Pike’s Peak was more rapid than at Climax, 
where a transient decrease initially occurred. 
Key variables identified in the Climax study 
were glucose-6-phosphate, fructose diphos- 
phate, dihydroxyacetone phosphate, 2-phos- 
phoglycerate, phosphoenolpyruvate, and the 
ratio of adenosine diphosphate to adenosine 
triphosphate (Fig. 2). At Pike’s Peak, the key 
variables were glucose-6-phosphate, 3-phos- 
phoglycerate, phosphoenolpyruvate, and the 
ratio of adenosine diphosphate to  adenosine 
triphosphate levels (Fig. 2). Inspecting their 
positions in the glycolytic pathway reveals 
that, among the key variables common to both 
studies, adenosine diphosphateladenosine 
triphosphate is involved at  the four kinase 
steps, glucose-6-phosphate is the product of the 
hexokinase step and the substrate for phospho- 
glucose isomerase, and phosphoenolpyruvate is 
the pyruvate kinase substrate and the enolase 
product (Fig. 2). Additional key variables a t  
Climax (fructose diphosphate, dihydroxyace- 
tone phosphate, 8-phosphoglycerate) partici- 
pate in the phosphofructokinase, aldolase, 
triose phosphate isomerase, phosphoglucomu- 
tase and enolase steps. At Pike’s Peak, the 
additional key variable (3-phosphoglycerate) is 
the product of the diphosphoglycerate phospha- 
tase step and the substrate for the phosphoglu- 
comutase step (Fig. 2). 
Among the key variables, the ratio of 
adenosine diphosphate to adenosine triphos- 
phate decreased at Pike’s Peak, glucose-6- 
phosphate levels increased in both studies, and 
phosphoenolpyruvate levels changed during 
both short-term studies. Additional glycolytic 
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Fig. 1. Time course of changes in mean 2,3-DPG levels. Samples sizes = 10 for Pike’s Peak (4300 m) and 
Climax (3400 m) at  each measurement time. 
TABLE 1. Glycolytic and hematologic uariables during climax 13400 mi study 1n = 10) 
Ann Arbor 
Variable baseline 6 Hours 2Days 4Days 6 Days 8Days T’test 
2,3-DPG1 
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9436 P < .05 
54 P < .05 
,113 
15 
1.4 P < .05 
14 
88 P < .05 
12 
18 P < .05 
46 
939 P < .05 
15.8 P < .05 
~~ ~~ 
1 Variables are expressed In pmolesiliter RBC water except a s  indicated otherwise. W.B. = whole blood. 
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TABLE 2. Glycolytic and hematologic uariables during Pike’s Peak 14300 mi 
study (n = 10) 
Denver 
Variable baseline 6 Hours 2 Days 4Days 7 Days 10 Days T’test 
2,3 DPG’ 7830 8304 9413 8839 8013 8326 P i .05 
ADP/ATP ratio, units .179 ,132 .154 .147 ,201 ,164 P i  .05 
Glucose-6-phosphate 58 55 60 64 60 64 P i .05 
Fructose diphosphate 2.0 3.2 4.3 4.0 4.7 4.6 P i .05 
Dihydroxyacetone 
3-Phosphoglycerate 81 89 98 88 94 93 P i  .05 
2-Phosphoglycerate 33 14 10 15 13 12 
Fructose-6-phosphate 14 11 12 12 13 12 
phosphate 15 17 20 16 21 17 
Phosphoenolpyruvate 27 25 27 20 29 20 P <  .05 
Pyruvate +molesfliter W.B. 56 58 53 58 47 63 
Lactate pmolesfliter W.B. 855 1149 944 1404 930 1408 
Hemoglobin g/lOO ml W.B. 16.0 16.3 15.9 16.6 16.2 17.4 P i .05 
‘ Variables are expressed in pmolesiliter RBC water unless indicated otherwise. W.B. = whole blood. 
tose diphosphate and 3-phosphoglycerate. Lac- 
tate levels increased during the Climax study 
(Tables 1 and 2). 
Long-term studies (Leadville and Ann Arbor) 
2,3-DPG levels among Leadville residents 
with chronic mountain polycythemia were 
higher than those of Ann Arbor residents. The 
2,3-DPG levels of Leadville normals also 
tended to be higher, but differences with Ann 
Arbor values were not statistically significant 
(Table 3). 
Key variables could not be identified in 
either the Ann Arbor normal or Leadville nor- 
mal samples due to the absence of significant 
relationships between 2,3-DPG and other 
glycolytic variables. In the Leadville polycy- 
themic sample, key variables were glucose-6- 
phosphate, fructose-6-phosphate, dihydroxy- 
acetone phosphate, and the ratio of adenosine 
diphosphate to adenosine triphosphate levels. 
These variables are found principally in the 
early enzymatic steps of glycolysis (Fig. 3) 
where glucose-6-phosphate is produced at the 
hexokinase step, fructose-6-phosphate is the 
substrate and fructose diphosphate is the prod- 
uct of the phosphofructokinase step, dihy- 
droxyacetone phosphate is the product of the 
aldolase step and the substrate for triose phos- 
phate isomerase, and the adenosine diphos- 
phateladenosine triphosphate ratio is a cofactor 
for each of the kinase steps (Fig. 3).  
Dihydroxyacetone phosphate, 3-phosphogly- 
cerate, and lactate levels were elevated in the 
Leadville polycythemic subjects, and phos- 
phoenolpyruvate values were lower compared 
to the Ann Arbor sample. Among these, only 
dihydroxyacetone phosphate was a key vari- 
able. 3-Phosphoglycerate and phosphoenolpy- 
ruvate were also variables undergoing change 
in the Leadville normal subjects (Table 3). 
DISCUSSION 
Erythrocyte 2,3-DPG levels increased during 
short-term exposure to 3400 m and to 4300 m 
and after long-term exposure in subjects with 
chronic mountain polycythemia. Hypoxia 
would appear to  be the primary stimulus, but 
the mechanisms by which hypoxia stimulates 
an increase in red blood cell 2,3-DPG levels are 
not clear. One mechanism is probably al- 
kalosis, induced by hyperventilation, which in 
turn stimulates in vivo phosphofructokinase 
activity. However, this mechanism is not solely 
responsible for elevating 2,3-DPG levels since 
2,3-DPG levels are known to increase in the 
absence of pH changes (Cymerman et al., ’76) 
and patterns of change in the levels of glycoly- 
tic intermediates have been observed during 
hypoxia that are consistent with the activation 
of other enzymes (Moore et al., ’72). 
The present study identified “key variables,” 
defined as those glycolytic intermediates on 
which variation in 2,3-DPG levels was depen- 
dent (r2, p < .05). The positions of these vari- 
ables in the glycolytic pathway pointed to en- 
zyme steps potentially involved in 2,3-DPG 
regulation during short-term high-altitude ex- 
posure (Fig. 2) and among Leadville residents 
with chronic mountain polycythemia (Fig. 3). 
Since each key variable involves a minimum of 
two enzymes (the enzyme producing and the 
enzyme catabolizing the intermediate), the 
task remains to  determine for each study which 
enzymes were most likely involved in 2,3-DPG 
regulation. 
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Fig. 2. Key variables (in boxes) in short-term studies. 
ABBREVIATIONS 
ATP, adenosine tnphosphate 
ADP, adenosine diphosphate 
hk, hexokinase 
G6P, glucose-6-phosphate 
pgi, phosphohexose isomerase 
F6P, fructose-6-phosphate 
pfk, 6-phosphofructokinase 
FDP, fructose 1,6-diphosphate 
ald, adolase 
GAP, glyceraldehyde 3-phosphate 
tpi, triosephosphate isomerase 
DHAP, dihydroxyacetone phosphate 
ga-3-pd, gl yceraldehyde-3-phosphate dehydrogenase 
1,3 DPG, 1,3-diphosphoglycerate 
2,3 DPG, 2,3 diphosphoglycerate 
pgk, 3-phosphoglycerate kinase 
dpgp, 2,3-diphosphoglycerate phosphatase 
3PG, 3 phosphoglycerate 
pgym, 2,3-phosphoglycerate mutase 
2PG, 2 phosphoglycerate 
en, enolase 
PEP, phosphoenolpyruvate 
pk, pyruvate kinase 
PYR, pyruvate 
ldh, lactate dehydrogenase 
LACT,lactate 
. 
dpgm, diphosphoglycerate mutase 
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TABLE 3. Variables measured in groups of high (3100 m) low (240 m) 
altitude residents 
(1) (2) (3) t-test 
Leadville Leadville Ann Arbor 
Variable polycythemics normals normals (1) vs (3) (2) vs (3) 
2,3-DPG' 










g/lOO ml W.B. 
phosphate 
h v a t e ,  
Lactate, 
Hemoglobin, 
8823 % 225 
.110 
58 t 3 
17 k 1 
3.0 2 .5 
22 * 2 
100 t 5 
1 2 2  1 
18 k 1 
50 -+ 5 
1284 * 153 
19.0 2 .4 
8535 ? 142 
,127 
55 -+ 2 
15 t 1 
1.8 % .2 
14 r 2 
104 t 4 
12 t 1 
19 t 1 
42 ? 4 
888 ? 52 
17.3 ? .2 
8167 ? 122 
.120 
53 % 2 
12 f 2 
2.5 t .3 
1 2 k  1 P < .05 
71 f 6 P < .05 P < .05 
11 f 2 
23 k 1 P < .05 P < .05 
46 r 4 
729 t 72 
P < .05 
P < .05 
15.8 * 0.2 P < .05 P < .05 
1 Variables are expressed in pmoies/liter RBC water except as indicated otherwise. W.B. = whole blood. 
In both the short-term studies, glucose-6- 
phosphate, phosphoenolpyruvate, and the ratio 
of adenosine diphosphate to  adenosine triphos- 
phate were identified as key variables. Four 
other variables were determined to be key 
variables in one or the other of the two studies 
(Fig. 2). Distinguishing the ratio of adenosine 
diphosphate to  adenosine triphosphate as a key 
variable is not very specific, since those cofac- 
tors are involved in all of the four kinase steps 
of the glycolytic pathway. However, the deter- 
mination of glucose-6-phosphate and phos- 
phoenolpyruvate as key variables in both 
studies suggests important roles for two of the 
kinases, hexokinase and pyruvate kinase, in 
the modulation of glycolysis a t  high altitude. 
Since both hexokinase and pyruvate kinase are 
rate-limiting steps in glycolysis (Minakami 
and Yoshikawa, '66), glucose-6-phosphate and 
phosphoenolpyruvate levels are more likely a 
reflection of their activities than of the non- 
rate-limiting enzymes, phosphoglucose isom- 
erase and enolase. In the Climax study, the 
identification of fructose diphosphate and di- 
hydroxyacetone phosphate suggest that a third 
kinase and the third rate-limiting enzyme, 
phosphofructokinase, is also involved in 2,3- 
DPG regulation. 
The absence of key variables in the Leadville 
normal residents and similarity in intermedi- 
ate levels with Ann Arbor residents suggests 
the completion of acclimatization in the Lead- 
ville group renders them no longer hypoxic. If 
so, hypoxia must be present in order to identify 
key variables on which 2,3-DPG levels are de- 
pendent. 
The key variables identified in the Leadville 
residents with chronic mountain polycythemia 
parallel to a certain extent those of the short- 
term studies (Fig. 3 compared with Fig. 2): the 
ratio of adenosine diphosphate to adenosine 
triphosphate and glucose-6-phosphate are key 
variables shared with both short-term studies; 
fructose diphosphate and dihydroxyacetone 
phosphate are common to the Climax study; 
and fructose-6-phosphate is unique to the 
Leadville polycythemics. These key variables 
suggest the involvement of the enzymes in the 
initial part of the glycolytic pathway with 2,3- 
DPG regulation in Leadville polycythemic 
sample. Of the four kinases implicated by the 
adenosine diphosphate to adenosine triphos- 
phate ratio, hexokinase and phosphofructoki- 
nase are rate-limiting enzymes positioned in 
the initial part of the pathway. The absence of 
phosphoenolpyruvate or other intermediates 
from the latter part of the pathway suggests 
that the third rate-limiting enzyme, pyruvate 
kinase, is not involved in the Leadville polycy- 
themic sample. 
Hexokinase, phosphofructokinase, and 
pyruvate kinase normally operate under par- 
tial inhibition. Since the mature red blood cell 
does not synthesize new protein, the maximal 
activities (Vmax) of the enzymes would not be 
expected to change at high altitude. An in- 
crease in in vivo activities of the enzymes due to 
release of partial inhibition is the probable 
mechanism by which the 2,3-DPG build-up oc- 
curs. Information on glucose consumption or 
flux through the pathway is needed, however, 
to  substantiate increased activity. Published 





Fig. 3. Key variables (in boxes) in Leadville residents with chronic mountain polycythemia. 
data on glucose consumption are not available, 
and our unpublished observations have shown 
inconsistent results. A difficulty arises in that 
available methods measure glucose consump- 
tion during an in vitro incubation where the 
stimuli affecting glycolysis may not be the 
same as those operating on the red blood cell in 
vivo. Also, changes in flux in vivo may be below 
limits of detection (i.e. an increase of 1%) yet 
still be sufficient to result in the observed 2,3- 
DPG changes. Tentatively, we believe that flux 
increases, at least early in short-term high- 
altitude exposure, since nearly all the glycoly- 
tic intermediates increase during the first six 
hours or two days (Tables 1 and 2). Without an 
increase in flux, it seems unlikely that inter- 
mediates positioned along the length of the 
glycolytic pathway would all increase. Also, the 
increase in glucose-6-phosphate levels in both 
short-term studies and the decrease in the ratio 
of adenosine diphosphate to adenosine triphos- 
phate at Pike's Peak supports hexokinase ac- 
tivation. The decreased adenosine diphosphate 
to adenosine triphosphate ratio at Pike's Peak 
is also consistent with pyruvate kinase activa- 
tion. Among key variables in the Leadville 
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polycythemic sample, lower adenosine diphos- 
phate to  adenosine triphosphate ratios and 
higher dihydroxyacetone phosphate levels 
support hexokinase and phosphofructokinase 
activation. Furthermore, the analysis used to 
identify the key variables supports activation, 
since the key variable selection was based on 
the close relationship between variation in the 
particular intermediate or cofactor with varia- 
tion in 2,3-DPG levels a t  each measurement 
time and under each altitude condition. 
Previous methods for interpreting changes in 
red blood cell metabolism at high altitude or in 
selected disease states have relied on the cross- 
over plot method of Chance et al. ('58) in which 
the levels of intermediates after hypoxic 
stimulus or in patients were plotted as a per- 
cent change of their prehypoxic levels or of the 
levels of a control group (Oelshlegel et al., '72; 
Moore et al., '72; Rorth et al., '72). The limi- 
tations of this approach are (1) that compari- 
sons between a subject's intermediate levels at 
two times or between two groups of subjects 
cannot rigorously take account of variation 
over multiple times or variation within a group 
of subjects and (2) that comparisons permitted 
do not lend themselves to hypothesis testing 
and the determination of statistical signifi- 
cance. 
Results of this study differ from those of pre- 
vious reports on red blood cell metabolic 
changes responsible for 2,3-DPG build-up at  
high altitude in which only phosphofructoki- 
nase activation was identified (Duhm and Ger- 
lach, '71; Rorth et al., '72). The stimulatory 
effect of alkalosis on phosphofructokinase has 
been used previously to support phosphofruc- 
tokinase as the responsible mechanism. The 
quantitative approach of the present study also 
identified phosphofructokinase activation, but 
only in the Climax short-term study and among 
high-altitude residents with chronic mountain 
polycythemia. Roles for pyruvate kinase in the 
Climax and Pike's Peak short-term studies and 
for hexokinase in both short-term studies and 
in the Leadville polycythemics point to the im- 
portance of additional portions of the glycolytic 
pathway in the regulation of 2,3-DPG levels at 
high altitude. Further research is needed to  
identify the stimuli operating on these enzymes 
as well as to determine whether genetic varia- 
tion exists in glycolytic enzymes among high 
altitude populations which may lead to differ- 
ences in enzymatic activities. 
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